Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03362060 |
Title | PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Massachusetts General Hospital |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |